• 1
    Engel J Jr, Kuhl DE, Phleps ME, et al. Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol 1982;12: 5107.
  • 2
    Theodore WH, Newmark ME, Sato S, et al. [18F]Fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Ann Neurol 1983;14: 42937.
  • 3
    Abou-Khalil BW, Siegel GJ, Sackellares JC, et al. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Ann Neurol 1987;22: 4806.
  • 4
    Engel J Jr, Henry TR, Risinger MW, et al. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology 1990;40: 16707.
  • 5
    Theodore WH, Sato S, Kufta C, et al. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol 1992;32: 78994.
  • 6
    Radtke RA, Hanson MW, Hoffman JM, et al. Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology 1993;10: 8892.
  • 7
    Manno EM, Sperling MR, Ding X, et al. Predictors of outcome after temporal lobectomy: positron emission tomography. Neurology 1994;44: 23316.
  • 8
    Gaillard WD, Bhatia S, Bookheimer SY, et al. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 1995;45: 1236.
  • 9
    Semah F, Baulac M, Hasboun D, et al. Is interictal temporal hypometabolism related to mesial temporal sclerosis? A positron emission tomography/magnetic resonance imaging confrontation. Epilepsia 1995;36: 44756.
  • 10
    Henry TR, Babb TL, Engel J Jr, et al. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy. Ann Neurol 1994;36: 9257.
  • 11
    O'Brien TJ, Newton MR, Cook MJ, et al. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy. Epilepsia 1997;38: 7480.
  • 12
    Foldvary N, Lee N, Hanson MW, et al. Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy. Epilepsia 1999;40: 269.
  • 13
    Azoulay-Zohar H, Aflalo C. Binding of rat brain hexokinase to recombinant yeast mitochondria. Identification of necessary physico-chemical determinants. Eur J Biochem 2000;267: 297380.
  • 14
    Elger CE, Hufnagel A, Schramm J. Protocol for surgery of epilepsy in Bonn. In: LudersHO, ed. Epilepsy surgery. New York: Raven Press, 1992: 7835.
  • 15
    Bronen RA, Cheung G, Charles JT, et al. Imaging findings in hippocampal sclerosis: correlation with pathology. Am J Neuroradiol 1991;12: 93340.
  • 16
    Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients. J Neurol Neurosurg Psychiatry 1995;58: 66673.
  • 17
    O'Brien TJ, O'Connor MK, Mullan BP, et al. Subtraction ictal SPET co-registered to MRI in partial epilepsy: description and technical validation of the method with phantom and patient studies. Nucl Med Commun 1998;19: 3145.
  • 18
    Henry TR, Mazziotta JC, Engel J Jr, et al. Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cereb Blood Flow Metab 1990;10: 74857.
  • 19
    Theodore WH, Fishbein P, Dubinsky R. Patterns of cerebral glucose metabolism in patients with partial seizures. Neurology 1988;38: 12016.
  • 20
    Hajek M, Antonini A, Leenders KL, et al. Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography. Neurology 1993;43: 7986.
  • 21
    Babb TL, Pretorius JK. Pathological substrates of epilepsy. In: WileyE, ed. The treatment of epilepsy: principles and practice. Philadelphia: Lea & Febiger, 1993: 5570.
  • 22
    Blumcke I, Sutter B, Behle K, et al. Loss of hilar mossy cells in Ammon's horn sclerosis. Epilepsia 2000;41: 17480.
  • 23
    Kunz WS, Kudin AP, Vielhaber S, et al. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 2000;48: 76673.
  • 24
    Kudin A, Vielhaber S, Beck H, et al. Quantitative investigation of mitochondrial function in single rat hippocampal slices: a novel application of high-resolution respirometry and laser-excited fluorescence spectroscopy. Brain Res Prot 1999;4: 32934.
  • 25
    Sackellares JC, Siegel GJ, Abou-Khalil BW, et al. Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology 1990;40: 14206.
  • 26
    Lencz T, McCarthy G, Bronen RA, et al. Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and neuropsychological function. Ann Neurol 1992;31: 62937.
  • 27
    Margerison JH, Corsellis JA. Epilepsy and the temporal lobes: a clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966;89: 499530.
  • 28
    Cottrell DA, Turnbull DM. Mitochondria and ageing. Curr Opin Clin Nutr Metab Care 2000;3: 4738.
  • 29
    Cottrell DA, Blakely EL, Johnson MA, et al. Mitochondrial enzyme-deficient hippocampal neurons and choriodal cells in AD. Neurology 2001;57: 2604.
  • 30
    Theodore WH, Gaillard WD, De Carli C, et al. Hippocampal volume and glucose metabolism in temporal lobe epileptic foci. Epilepsia 2001;42: 1302.
  • 31
    Engel J Jr, Van Ness PC, Rasmussen TB, et al. Outcome with respect to epileptic seizures. In: EngelJJr, ed. Surgical treatment of the epilepsies. New York: Raven Press, 1993: 60921.